PI3KCA mutation status is of limited prognostic relevance in ER-positive breast cancer patients treated with hormone therapy.
Cuorvo LV, Verderio P, Ciniselli CM, Girlando S, Decarli N, Leonardi E, Ferro A, Caldara A, Triolo R, Eccher C, Cantaloni C, Mauri F, Seckl M, Volante M, Buttitta F, Marchetti A, Silvia Q, Galligioni E, Palma PD, Barbareschi M.
Cuorvo LV, et al. Among authors: ciniselli cm.
Virchows Arch. 2014 Jan;464(1):85-93. doi: 10.1007/s00428-013-1500-7.
Virchows Arch. 2014.
PMID: 24233241